600594 益佰制药
已收盘 06-30 15:00:00
资讯
新帖
简况
每周股票复盘:益佰制药(600594)将召开临时股东会审议董监换届
证券之星 · 06-28
每周股票复盘:益佰制药(600594)将召开临时股东会审议董监换届
益佰制药(600594)披露2026年第一次临时股东会会议资料,6月26日股价下跌3.91%
证券之星 · 06-26
益佰制药(600594)披露2026年第一次临时股东会会议资料,6月26日股价下跌3.91%
益佰制药(600594)披露2026年第一次临时股东会通知,6月16日股价下跌1.52%
证券之星 · 06-16
益佰制药(600594)披露2026年第一次临时股东会通知,6月16日股价下跌1.52%
每周股票复盘:益佰制药(600594)拟注销753万回购股份
证券之星 · 05-24
每周股票复盘:益佰制药(600594)拟注销753万回购股份
益佰制药(600594)披露变更回购股份用途并注销暨通知债权人公告,5月20日股价下跌2.81%
证券之星 · 05-20
益佰制药(600594)披露变更回购股份用途并注销暨通知债权人公告,5月20日股价下跌2.81%
每周股票复盘:益佰制药(600594)将举办2025年度业绩说明会
证券之星 · 05-02
每周股票复盘:益佰制药(600594)将举办2025年度业绩说明会
益佰制药(600594)披露将参加2026年贵州辖区上市公司投资者集体接待日活动暨2025年度业绩说明会,4月30日股价下跌1.7%
证券之星 · 04-30
益佰制药(600594)披露将参加2026年贵州辖区上市公司投资者集体接待日活动暨2025年度业绩说明会,4月30日股价下跌1.7%
每周股票复盘:益佰制药(600594)一季度净利亏损2952万
证券之星 · 04-26
每周股票复盘:益佰制药(600594)一季度净利亏损2952万
益佰制药(600594)2026年一季报简析:净利润同比下降214.57%
证券之星 · 04-24
益佰制药(600594)2026年一季报简析:净利润同比下降214.57%
图解益佰制药年报:第四季度单季净利润同比下降64.12%
证券之星 · 04-23
图解益佰制药年报:第四季度单季净利润同比下降64.12%
异动快报:益佰制药(600594)4月21日9点33分触及涨停板
证券之星 · 04-21
异动快报:益佰制药(600594)4月21日9点33分触及涨停板
每周股票复盘:益佰制药(600594)近5日3次登上龙虎榜
证券之星 · 04-19
每周股票复盘:益佰制药(600594)近5日3次登上龙虎榜
异动快报:益佰制药(600594)4月15日14点52分触及涨停板
证券之星 · 04-15
异动快报:益佰制药(600594)4月15日14点52分触及涨停板
4月13日益佰制药(600594)龙虎榜数据
证券之星 · 04-13
4月13日益佰制药(600594)龙虎榜数据
每周股票复盘:益佰制药(600594)近5日4次登龙虎榜
证券之星 · 04-12
每周股票复盘:益佰制药(600594)近5日4次登龙虎榜
4月9日益佰制药(600594)涨停分析:新药获批、成本优化驱动
证券之星 · 04-09
4月9日益佰制药(600594)涨停分析:新药获批、成本优化驱动
股市必读:益佰制药(600594)4月8日收盘跌8.18%,主力净流出701.79万元
证券之星 · 04-09
股市必读:益佰制药(600594)4月8日收盘跌8.18%,主力净流出701.79万元
4月7日益佰制药(600594)龙虎榜数据
证券之星 · 04-07
4月7日益佰制药(600594)龙虎榜数据
每周股票复盘:益佰制药(600594)近5日3次登上龙虎榜
证券之星 · 04-05
每周股票复盘:益佰制药(600594)近5日3次登上龙虎榜
益佰制药(600594)披露股票交易异常波动公告,4月3日股价下跌2.08%
中金财经 · 04-03
益佰制药(600594)披露股票交易异常波动公告,4月3日股价下跌2.08%
加载更多
公司概况
公司名称:
贵州益佰制药股份有限公司
所属行业:
医药制造业
上市日期:
2004-03-23
主营业务:
贵州益佰制药股份有限公司的主营业务是药品的研发、生产和销售,综合性医院、肿瘤专科医院、肿瘤放疗中心的运营与管理,开发、研制、生产及销售以苗药为特色的大健康产品。公司的主要产品是注射用洛铂、银杏达莫注射液、抗肿瘤类、心脑血管类、男科类、妇科类、其他、注射用瑞替普酶、科博肽、医疗服务、糖果、植物饮料、膏滋。
发行价格:
14.40
{"stockData":{"symbol":"600594","market":"SH","secType":"STK","nameCN":"益佰制药","latestPrice":2.97,"timestamp":1782802801000,"preClose":3.05,"halted":0,"volume":17589200,"delay":0,"changeRate":-0.0262,"floatShares":792000000,"shares":792000000,"eps":-0.4416,"marketStatus":"已收盘","change":-0.08,"latestTime":"06-30 15:00:00","open":3.05,"high":3.06,"low":2.94,"amount":52510000,"amplitude":0.0393,"askPrice":2.98,"askSize":2692,"bidPrice":2.97,"bidSize":3906,"shortable":0,"etf":0,"ttmEps":-0.4416,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782869400000},"marketStatusCode":5,"adr":0,"adjPreClose":3.05,"symbolType":"stock","openAndCloseTimeList":[[1782783000000,1782790200000],[1782795600000,1782802800000]],"highLimit":3.36,"lowLimit":2.75,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":791927400,"isCdr":false,"pbRate":1.09,"roa":"--","roe":"--","epsLYR":-0.42,"committee":0.305767,"marketValue":2352000000,"turnoverRate":0.0222,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-07-02。","floatMarketCap":2352000000},"requestUrl":"/m/hq/s/600594","defaultTab":"news","newsList":[{"id":"2646315822","title":"每周股票复盘:益佰制药(600594)将召开临时股东会审议董监换届","url":"https://stock-news.laohu8.com/highlight/detail?id=2646315822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646315822?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:00","pubTimestamp":1782586836,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,益佰制药报收于2.95元,较上周的3.11元下跌5.14%。本周关注点公司公告汇总:益佰制药将召开2026年第一次临时股东会审议董事会换届人选公司公告汇总:非独立董事候选人包括窦启玲、窦雅琪、曾宪体公司公告汇总:独立董事候选人名单为彭文宗、陈轩、梁亮公司公告汇总贵州益佰制药股份有限公司将于2026年7月2日召开2026年第一次临时股东会,采用现场与网络投票相结合方式。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600594","BK0096","BK0060","BK0097","BK0039","BK0239","BK0077","BK0188","BK0070","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365444","title":"益佰制药(600594)披露2026年第一次临时股东会会议资料,6月26日股价下跌3.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646365444?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:40","pubTimestamp":1782484823,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,益佰制药报收于2.95元,较前一交易日下跌3.91%,最新总市值为23.36亿元。该股当日开盘3.07元,最高3.08元,最低2.94元,成交额达5804.48万元,换手率为2.45%。近日,贵州益佰制药股份有限公司披露《2026年第一次临时股东会会议资料》。公告显示,公司将于2026年7月2日召开2026年第一次临时股东会,采用现场与网络投票相结合方式。候选人简历及任职情况已在会议资料中披露,包括持股情况、关联关系及任职资格说明。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600045880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0188","BK0012","BK0028","BK0097","BK0039","600594","BK0060","BK0077","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643714763","title":"益佰制药(600594)披露2026年第一次临时股东会通知,6月16日股价下跌1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643714763","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643714763?lang=zh_cn&edition=full","pubTime":"2026-06-16 22:38","pubTimestamp":1781620698,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘,益佰制药报收于3.24元,较前一交易日下跌1.52%,最新总市值为25.66亿元。该股当日开盘3.29元,最高3.29元,最低3.19元,成交额达4465.84万元,换手率为1.75%。近日,贵州益佰制药股份有限公司发布《关于召开2026年第一次临时股东会的通知》。股权登记日为2026年6月25日,登记时间截至2026年7月1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600044361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600594","BK0060","BK0012","BK0039","BK0077","BK0097","BK0188","BK0070","BK0239","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637137577","title":"每周股票复盘:益佰制药(600594)拟注销753万回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2637137577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637137577?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:20","pubTimestamp":1779567622,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,益佰制药报收于3.72元,较上周的3.92元下跌5.1%。本周,益佰制药5月19日盘中最高价报3.92元。本周关注点来自公司公告汇总:益佰制药拟将已回购的7,533,500股股份注销,注册资本相应减少。贵州益佰制药股份有限公司于2026年4月至5月期间经董事会及年度股东大会决议,将已回购的7,533,500股股份用途由“用于员工持股计划或股权激励”变更为“用于注销并相应减少注册资本”。本次注销后,公司总股本将由791,927,400股调整为784,393,900股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0070","BK0028","BK0097","BK0039","BK0096","BK0239","BK0077","BK0188","600594","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636825511","title":"益佰制药(600594)披露变更回购股份用途并注销暨通知债权人公告,5月20日股价下跌2.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636825511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636825511?lang=zh_cn&edition=full","pubTime":"2026-05-20 22:33","pubTimestamp":1779287597,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,益佰制药报收于3.81元,较前一交易日下跌2.81%,最新总市值为30.17亿元。近日,贵州益佰制药股份有限公司发布《关于变更回购股份用途并注销暨通知债权人的公告》。公告显示,公司于2026年4月至5月期间召开董事会及年度股东大会,审议通过将已回购的7,533,500股股份用途由“用于员工持股计划或股权激励”变更为“用于注销并相应减少注册资本”。本次注销后,公司总股本将由791,927,400股变更为784,393,900股,注册资本相应减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000043443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0077","BK0097","BK0028","BK0060","600594","BK0070","BK0096","BK0239","BK0039","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632977623","title":"每周股票复盘:益佰制药(600594)将举办2025年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2632977623","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632977623?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:09","pubTimestamp":1777673360,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,益佰制药报收于4.05元,较上周的4.33元下跌6.47%。本周关注点公司公告汇总:贵州益佰制药将于2026年5月11日举行2025年度业绩说明会,管理层将与投资者在线交流。公司公告汇总:益佰制药召开2025年年度股东会,审议利润分配预案、董事薪酬方案等多项议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0060","600594","BK0028","BK0097","BK0012","BK0096","BK0077","BK0039","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631720655","title":"益佰制药(600594)披露将参加2026年贵州辖区上市公司投资者集体接待日活动暨2025年度业绩说明会,4月30日股价下跌1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631720655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631720655?lang=zh_cn&edition=full","pubTime":"2026-04-30 22:13","pubTimestamp":1777558399,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,益佰制药报收于4.05元,较前一交易日下跌1.7%,最新总市值为32.07亿元。近日,贵州益佰制药股份有限公司发布《关于参加“2026年贵州辖区上市公司投资者集体接待日活动暨2025年度业绩说明会”的公告》。投资者可于公告发布日至2026年5月8日12:00前通过“贵州资本市场”微信公众号提交问题。公司已于2026年4月23日披露2025年年度报告,本次说明会将就财务状况、经营成果等与投资者交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000068743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0039","BK0070","BK0239","BK0028","600594","BK0188","BK0077","BK0060","BK0096","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630680172","title":"每周股票复盘:益佰制药(600594)一季度净利亏损2952万","url":"https://stock-news.laohu8.com/highlight/detail?id=2630680172","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630680172?lang=zh_cn&edition=full","pubTime":"2026-04-26 02:56","pubTimestamp":1777143370,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,益佰制药报收于4.33元,较上周的4.5元下跌3.78%。本周,益佰制药4月21日盘中最高价报5.04元。本周关注点来自业绩披露要点:益佰制药2026年一季报显示归母净利润-2952.49万元,同比下降214.57%。股本股东变化股东户数变动截至2026年3月31日,益佰制药股东户数为4.59万户,较2025年12月31日减少2914户,减幅5.97%。贵州益佰制药股份有限公司关于2025年年度利润分配预案公告公司2025年度拟不进行利润分配,亦不进行资本公积金转增股本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0039","BK0070","BK0239","BK0028","600594","BK0188","BK0077","BK0060","BK0096","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629847094","title":"益佰制药(600594)2026年一季报简析:净利润同比下降214.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629847094","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629847094?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:11","pubTimestamp":1777039865,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期益佰制药发布2026年一季报。根据财报显示,益佰制药净利润同比下降214.57%。截至本报告期末,公司营业总收入3.59亿元,同比下降28.44%,归母净利润-2952.49万元,同比下降214.57%。本次财报公布的各项数据指标表现不尽如人意。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400064627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600594"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629802960","title":"图解益佰制药年报:第四季度单季净利润同比下降64.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629802960","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629802960?lang=zh_cn&edition=full","pubTime":"2026-04-23 01:03","pubTimestamp":1776877402,"startTime":"0","endTime":"0","summary":"证券之星消息,益佰制药2025年年报显示,当年度公司主营收入18.63亿元,同比下降14.31%;归母净利润-3.3亿元,同比下降3.89%;扣非净利润-3.25亿元,同比下降0.59%;其中2025年第四季度,公司单季度主营收入4.16亿元,同比下降9.56%;单季度归母净利润-2.43亿元,同比下降64.12%;单季度扣非净利润-2.41亿元,同比下降67.65%;负债率34.03%,投资收益-21.46万元,财务费用2071.58万元,毛利率59.66%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300002111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600594"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629035687","title":"异动快报:益佰制药(600594)4月21日9点33分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2629035687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629035687?lang=zh_cn&edition=full","pubTime":"2026-04-21 09:35","pubTimestamp":1776735349,"startTime":"0","endTime":"0","summary":"证券之星4月21日盘中消息,9点33分益佰制药(600594)触及涨停板。其所属行业中药目前上涨。领涨股为康惠股份。该股为中药,医药,民营医院概念热股,当日中药概念上涨0.5%,医药概念上涨0.2%。4月20日的资金流向数据方面,主力资金净流入1096.19万元,占总成交额2.93%,游资资金净流入396.46万元,占总成交额1.06%,散户资金净流出1492.64万元,占总成交额4.0%。近5日资金流向一览见下表:益佰制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100016655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0028","BK0070","BK0077","BK0012","BK0096","BK0097","BK0239","600594","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628075657","title":"每周股票复盘:益佰制药(600594)近5日3次登上龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2628075657","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628075657?lang=zh_cn&edition=full","pubTime":"2026-04-19 01:33","pubTimestamp":1776533587,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,益佰制药报收于4.5元,较上周的4.81元下跌6.44%。本周,益佰制药4月16日盘中最高价报4.93元。4月14日盘中最低价报4.22元。本周共计1次涨停收盘,无跌停收盘情况。益佰制药当前最新总市值35.64亿元,在中药板块市值排名52/66,在两市A股市值排名4267/5198。本周关注点交易信息汇总:益佰制药因日收盘价格跌幅偏离值达7%连续5日内第3次登上龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0028","BK0070","BK0077","BK0012","BK0096","BK0097","BK0239","600594","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627406102","title":"异动快报:益佰制药(600594)4月15日14点52分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2627406102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627406102?lang=zh_cn&edition=full","pubTime":"2026-04-15 14:55","pubTimestamp":1776236123,"startTime":"0","endTime":"0","summary":"证券之星4月15日盘中消息,14点52分益佰制药触及涨停板。其所属行业中药目前上涨。领涨股为康恩贝。该股为中药,医药,民营医院概念热股,当日中药概念上涨2.14%,医药概念上涨1.81%,民营医院概念上涨0.4%。4月14日的资金流向数据方面,主力资金净流出1515.31万元,占总成交额3.81%,游资资金净流出844.29万元,占总成交额2.12%,散户资金净流入2359.6万元,占总成交额5.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500021799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0188","BK0097","BK0070","BK0039","BK0077","BK0096","600594","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627436971","title":"4月13日益佰制药(600594)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2627436971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627436971?lang=zh_cn&edition=full","pubTime":"2026-04-13 17:14","pubTimestamp":1776071651,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年4月13日公布的交易公开信息显示,益佰制药因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年4月13日收盘,益佰制药报收于4.42元,下跌8.11%,换手率15.36%,成交量121.66万手,成交额5.44亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300022341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0039","BK0239","BK0070","BK0188","BK0077","BK0012","BK0060","BK0097","600594","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626124175","title":"每周股票复盘:益佰制药(600594)近5日4次登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2626124175","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626124175?lang=zh_cn&edition=full","pubTime":"2026-04-12 01:09","pubTimestamp":1775927349,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘,益佰制药报收于4.81元,较上周的4.7元上涨2.34%。本周,益佰制药4月7日盘中最高价报5.11元。益佰制药当前最新总市值38.09亿元,在中药板块市值排名51/67,在两市A股市值排名4099/5196。沪深交易所2026年4月7日公布的交易公开信息显示,益佰制药因有价格涨跌幅限制的日价格振幅达到15%的前五只证券,有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。此次是近5个交易日内第4次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0012","BK0070","BK0188","BK0028","BK0039","BK0096","BK0097","600594","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626901038","title":"4月9日益佰制药(600594)涨停分析:新药获批、成本优化驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2626901038","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626901038?lang=zh_cn&edition=full","pubTime":"2026-04-09 15:35","pubTimestamp":1775720140,"startTime":"0","endTime":"0","summary":"证券之星消息,益佰制药4月9日涨停收盘,收盘价5.06元。今日益佰制药涨停的可能因素有:注射用阿扎胞苷获批药品注册证书,视同通过一致性评价,加速上市并拓展血液肿瘤治疗领域;产品管线丰富化增强抗风险能力;成本费用同比下降18%,经营效率改善;叠加中药Ⅱ板块联动及近期连续获龙虎榜曝光,市场关注度提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900019355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0070","BK0077","BK0012","BK0188","BK0096","BK0239","600594","BK0039","BK0097","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626261779","title":"股市必读:益佰制药(600594)4月8日收盘跌8.18%,主力净流出701.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2626261779","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626261779?lang=zh_cn&edition=full","pubTime":"2026-04-09 01:16","pubTimestamp":1775668571,"startTime":"0","endTime":"0","summary":"截至2026年4月8日收盘,益佰制药报收于4.6元,下跌8.18%,换手率17.87%,成交量141.55万手,成交额6.61亿元。来自龙虎榜上榜:益佰制药因日收盘价格跌幅偏离值达7%连续5个交易日登榜,市场波动加剧。交易信息汇总股价提醒4月8日益佰制药收盘报4.6元,跌8.18%,当日成交1.42亿元。资金流向4月8日主力资金净流出701.79万元,占总成交额1.06%;游资资金净流出833.48万元,占总成交额1.26%;散户资金净流入1535.27万元,占总成交额2.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900001056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0097","BK0188","BK0239","BK0096","BK0077","600594","BK0070","BK0012","BK0060","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625166936","title":"4月7日益佰制药(600594)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2625166936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625166936?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:14","pubTimestamp":1775553284,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年4月7日公布的交易公开信息显示,益佰制药因有价格涨跌幅限制的日价格振幅达到15%的前五只证券,有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。此次是近5个交易日内第4次上榜。截至2026年4月7日收盘,益佰制药报收于5.01元,上涨6.6%,换手率23.86%,成交量188.94万手,成交额8.97亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0060","600594","BK0028","BK0097","BK0012","BK0096","BK0077","BK0039","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625159086","title":"每周股票复盘:益佰制药(600594)近5日3次登上龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2625159086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625159086?lang=zh_cn&edition=full","pubTime":"2026-04-05 01:07","pubTimestamp":1775322431,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,益佰制药报收于4.7元,较上周的3.84元上涨22.4%。本周,益佰制药4月3日盘中最高价报5.27元,股价触及近一年最高点。本周关注点交易信息汇总:益佰制药近5个交易日内第3次因日换手率达20%等情形登上龙虎榜。沪深交易所2026年4月2日公布的交易公开信息显示,益佰制药因日收盘价格涨幅偏离值达到7%及连续三个交易日内累计偏离值达20%的情形登上龙虎榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0039","BK0070","BK0239","BK0028","600594","BK0188","BK0077","BK0060","BK0096","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624656402","title":"益佰制药(600594)披露股票交易异常波动公告,4月3日股价下跌2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624656402","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624656402?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:12","pubTimestamp":1775207523,"startTime":"0","endTime":"0","summary":"贵州益佰制药股份有限公司于2026年4月3日发布《股票交易异常波动的公告》。公告显示,公司股票于2026年3月31日至4月2日连续三个交易日内日收盘价格涨幅偏离值累计超过20%,构成股票交易异常波动。公司自查并问询控股股东及实际控制人,确认不存在应披露而未披露的重大信息。董事会确认无应披露未披露事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260403/32124840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","BK0077","600594","BK0060","BK0070","BK0012","BK0188","BK0039","BK0097","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782848781336,"stockEarnings":[{"period":"1week","weight":-0.0917},{"period":"1month","weight":-0.161},{"period":"3month","weight":-0.3188},{"period":"6month","weight":-0.2538},{"period":"1year","weight":-0.2286},{"period":"ytd","weight":-0.2538}],"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0369},{"period":"6month","weight":0.0316},{"period":"1year","weight":0.1887},{"period":"ytd","weight":0.0316}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"贵州益佰制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"45929人(较上一季度减少5.97%)","perCapita":"17242股","listingDate":"2004-03-23","address":"贵州省贵阳市云岩区白云大道220-1号","registeredCapital":"79192万元","survey":" 贵州益佰制药股份有限公司的主营业务是药品的研发、生产和销售,综合性医院、肿瘤专科医院、肿瘤放疗中心的运营与管理,开发、研制、生产及销售以苗药为特色的大健康产品。公司的主要产品是注射用洛铂、银杏达莫注射液、抗肿瘤类、心脑血管类、男科类、妇科类、其他、注射用瑞替普酶、科博肽、医疗服务、糖果、植物饮料、膏滋。","listedPrice":14.4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"益佰制药(600594)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供益佰制药(600594)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"益佰制药,600594,益佰制药股票,益佰制药股票老虎,益佰制药股票老虎国际,益佰制药行情,益佰制药股票行情,益佰制药股价,益佰制药股市,益佰制药股票价格,益佰制药股票交易,益佰制药股票购买,益佰制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"益佰制药(600594)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供益佰制药(600594)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}